FDA Approved: TAPENTADOL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental NDA for tapentadol hydrochloride by Hikma Pharmaceuticals USA Inc., allowing a generic version of tapentadol to enter the market.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathy
• Osteoarthritis
• Pain

Drugs mentioned

• Tapentadol hydrochloride (Tapentadol hydrochloride)

Snippet

SUPPL AP for TAPENTADOL (TAPENTADOL HYDROCHLORIDE)